142 related articles for article (PubMed ID: 34394221)
1. Association between osteoporosis and hepatitis B cirrhosis: a case-control study.
Zhang Y; Gao X; Liu T; Gao P; Li H; Liu N; Gao L; Wan G; Zhang Y; Duan X
Afr Health Sci; 2020 Dec; 20(4):1610-1616. PubMed ID: 34394221
[TBL] [Abstract][Full Text] [Related]
2. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
[TBL] [Abstract][Full Text] [Related]
3. Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation.
Monegal A; Navasa M; Guañabens N; Peris P; Pons F; Martinez de Osaba MJ; Rimola A; Rodés J; Muñoz-Gómez J
Calcif Tissue Int; 1997 Feb; 60(2):148-54. PubMed ID: 9056162
[TBL] [Abstract][Full Text] [Related]
4. [The role of biochemical markers of bone turnover in the diagnosis of osteoporosis and predicting fracture risk].
Mohamed Y; Haifa H; Datel O; Fadoua HN; Smeh BH; Mahbouba J; Saoussen Z; Bejia I; Mongi T; Mohamed FN; Naceur B
Tunis Med; 2014 May; 92(5):304-10. PubMed ID: 25504382
[TBL] [Abstract][Full Text] [Related]
5. Low bone mineral density in men with chronic obstructive pulmonary disease.
Duckers JM; Evans BA; Fraser WD; Stone MD; Bolton CE; Shale DJ
Respir Res; 2011 Aug; 12(1):101. PubMed ID: 21812978
[TBL] [Abstract][Full Text] [Related]
6. Metabolic bone disease of liver cirrhosis: is it parallel to the clinical severity of cirrhosis?
Chen CC; Wang SS; Jeng FS; Lee SD
J Gastroenterol Hepatol; 1996 May; 11(5):417-21. PubMed ID: 8743912
[TBL] [Abstract][Full Text] [Related]
7. Serum 25-hydroxyvitamin D and bone turnover markers in Palestinian postmenopausal osteoporosis and normal women.
Kharroubi A; Saba E; Smoom R; Bader K; Darwish H
Arch Osteoporos; 2017 Dec; 12(1):13. PubMed ID: 28124221
[TBL] [Abstract][Full Text] [Related]
8. An association between abnormal bone turnover, systemic inflammation, and osteoporosis in patients with chronic pancreatitis: a case-matched study.
Duggan SN; Purcell C; Kilbane M; O'Keane M; McKenna M; Gaffney P; Ridgway PF; Boran G; Conlon KC
Am J Gastroenterol; 2015 Feb; 110(2):336-45. PubMed ID: 25623657
[TBL] [Abstract][Full Text] [Related]
9. Calciotropic Hormones and the Prevalence of Vertebral Fractures in Chinese Postmenopausal Women with Vitamin D Insufficiency: Peking Vertebral Fracture Study.
Jiajue R; Jiang Y; Qi X; Wang Q; Wang W; Pei Y; Wang X; Huang W; Zheng X; Ning Z; Wang O; Li M; Xing X; Yu W; Xu L; Xia W
Calcif Tissue Int; 2019 Jun; 104(6):622-630. PubMed ID: 30737534
[TBL] [Abstract][Full Text] [Related]
10. [Clinical value of serum total P1NP, β-CTX and 25(OH)D3 detection in evaluating risks of fragile hip fracture in elderly patients with osteoporosis].
Lou H; Peng C; Chen Q
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Sep; 32(9):1346-9. PubMed ID: 22985580
[TBL] [Abstract][Full Text] [Related]
11. Bone mineral density and cytokine levels during interferon therapy in children with chronic hepatitis B: does interferon therapy prevent from osteoporosis?
Gur A; Dikici B; Nas K; Bosnak M; Haspolat K; Sarac AJ
BMC Gastroenterol; 2005 Sep; 5():30. PubMed ID: 16171525
[TBL] [Abstract][Full Text] [Related]
12. Bone mineral density loss in patients with cirrhosis.
Muhsen IN; AlFreihi O; Abaalkhail F; AlKhenizan A; Khan M; Eldali A; Alsohaibani F
Saudi J Gastroenterol; 2018; 24(6):342-347. PubMed ID: 29943736
[TBL] [Abstract][Full Text] [Related]
13. Reference intervals of β-C-terminal telopeptide of type I collagen, procollagen type I N-terminal propeptide and osteocalcin for very elderly Chinese men.
Shou Z; Jin X; Bian P; Li X; Chen J
Geriatr Gerontol Int; 2017 May; 17(5):773-778. PubMed ID: 27137883
[TBL] [Abstract][Full Text] [Related]
14. Associations of Bone Mineral Density and Bone Metabolism Indices with Urine Albumin to Creatinine Ratio in Chinese Patients with Type 2 Diabetes.
Zhao X; Zhang XM; Yuan N; Yu XF; Ji LN
Exp Clin Endocrinol Diabetes; 2019 Jan; 127(1):50-55. PubMed ID: 30396213
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D status & bone health in patients with liver cirrhosis.
Grover I; Singh N; Gunjan D; Benjamin J; Ramakrishnan L; Pandey RM; Sati HC; Saraya A
Indian J Med Res; 2023 Sep; 158(3):284-291. PubMed ID: 37815065
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and characteristics of bone disease in cirrhotic patients under evaluation for liver transplantation.
Alcalde Vargas A; Pascasio Acevedo JM; Gutiérrez Domingo I; García Jiménez R; Sousa Martín JM; Ferrer Ríos MT; Sayago Mota M; Giráldez Gallego A; Gómez Bravo MA
Transplant Proc; 2012; 44(6):1496-8. PubMed ID: 22841194
[TBL] [Abstract][Full Text] [Related]
17. Risk factors associated with hepatic osteopathy in HBV related cirrhosis measured by liver stiffness: An Observational study.
Zhang W; Gong H; Su Z; Zhang X; Cao S
Medicine (Baltimore); 2019 Aug; 98(31):e16628. PubMed ID: 31374030
[TBL] [Abstract][Full Text] [Related]
18. Sickle cell bone disease: response to vitamin D and calcium.
Adewoye AH; Chen TC; Ma Q; McMahon L; Mathieu J; Malabanan A; Steinberg MH; Holick MF
Am J Hematol; 2008 Apr; 83(4):271-4. PubMed ID: 17924548
[TBL] [Abstract][Full Text] [Related]
19. The heterogeneity of bone disease in cirrhosis: a multivariate analysis.
Crawford BA; Kam C; Donaghy AJ; McCaughan GW
Osteoporos Int; 2003 Dec; 14(12):987-94. PubMed ID: 14504696
[TBL] [Abstract][Full Text] [Related]
20. The levels of bone turnover markers in Chinese postmenopausal women: Peking Vertebral Fracture study.
Zhao J; Xia W; Nie M; Zheng X; Wang Q; Wang X; Wang W; Ning Z; Huang W; Jiang Y; Li M; Wang O; Xing X; Sun Y; Luo L; He S; Yu W; Lin Q; Pei Y; Zhang F; Han Y; Tong Y; Che Y; Shen R; Hu Y; Zhou X; Xu L
Menopause; 2011 Nov; 18(11):1237-43. PubMed ID: 21747303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
